Pierre Dessein

Pierre is the Co-founder and CEO of Bilhi Genetics, a company combining genetics and digital technology to predict and prevent serious diseases (cirrhosis, liver cancer, keloid scars...). Pierre studied law in France, Scotland and the USA and followed a program for entrepreneurs at HEC. He was an attorney-at-law in France and New York. He has worked in the M&A team of Groupe Danone in ShanghaÏ and Paris, and for law firms where he was mainly advising clients on private equity and M&A deals.